Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Common MOQs observed fall between 10 pieces and 200 pieces
Mounjaro (Tirzepatide) and the GIP Advantage Mounjaro introduces a dual-agonist approach by targeting both GLP-1 and GIP (Gastric Inhibitory Polypeptide) receptors
Patients can undergo a tummy tuck or body lift with their surgeon and then return to the same practice for RF microneedling, laser treatments, or injectable services all coordinated under one roof
Building Innovation: The First Precision Biology-Based Obesity Test Following the successful launch of its GLP Compass(), Digbi Health continues to innovate by expanding its obesity test capabilities in 2025
These tests help establish a baseline for liver, kidney, glucose, hormone, and recovery tracking
US$ 25.54
US$ 23.94
US$ 26.69
